Loading...
Merus announces appointment of Jason Avery as Chief Business Officer
19-Jun-2012
- Netherlands
Advertisement
Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced that Jason Avery has been appointed as Chief Business Officer.
With a professional background as Head of Business Development at Affitech A/S and Chief Business Officer at Cambridge Antibody Technology, Jason Avery brings extensive industry experience to Merus.